355 related articles for article (PubMed ID: 16325598)
1. Noninvasive prenatal RHD genotyping by real-time polymerase chain reaction using plasma from D-negative pregnant women.
Zhou L; Thorson JA; Nugent C; Davenport RD; Butch SH; Judd WJ
Am J Obstet Gynecol; 2005 Dec; 193(6):1966-71. PubMed ID: 16325598
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma.
Brojer E; Zupanska B; Guz K; Orziñska A; Kaliñska A
Transfusion; 2005 Sep; 45(9):1473-80. PubMed ID: 16131380
[TBL] [Abstract][Full Text] [Related]
3. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.
Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM
Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma.
Grootkerk-Tax MG; Soussan AA; de Haas M; Maaskant-van Wijk PA; van der Schoot CE
Transfusion; 2006 Dec; 46(12):2142-8. PubMed ID: 17176327
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis.
Kimura M; Sato C; Hara M; Ishihara O; Ikebuchi K
Transfusion; 2008 Jun; 48(6):1156-63. PubMed ID: 18422850
[TBL] [Abstract][Full Text] [Related]
6. The use of maternal plasma for prenatal RhD blood group genotyping.
Finning K; Martin P; Daniels G
Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R
J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma.
Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R
Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640
[TBL] [Abstract][Full Text] [Related]
9. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
10. RHD genotyping from maternal plasma: guidelines and technical challenges.
Avent ND
Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
[TBL] [Abstract][Full Text] [Related]
11. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
Al-Yatama MK; Mustafa AS; Al-Kandari FM; Khaja N; Zohra K; Monem RA; Abraham S
Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
[TBL] [Abstract][Full Text] [Related]
12. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA
Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive determination of fetal rh blood group, D antigen status by cell-free DNA analysis in maternal plasma: experience in a Brazilian population.
Chinen PA; Nardozza LM; Martinhago CD; Camano L; Daher S; Pares DB; Minett T; Araujo Júnior E; Moron AF
Am J Perinatol; 2010 Nov; 27(10):759-62. PubMed ID: 20408112
[TBL] [Abstract][Full Text] [Related]
14. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving.
Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM
Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782
[TBL] [Abstract][Full Text] [Related]
15. Preliminary results of fetal Rhc examination in plasma of pregnant women with anti-c.
Orzińska A; Guz K; Brojer E; Zupańska B
Prenat Diagn; 2008 Apr; 28(4):335-7. PubMed ID: 18382999
[TBL] [Abstract][Full Text] [Related]
16. Fetal RhD genotyping by analysis of maternal blood. A case report.
Tóth T; Papp C; Tóth-Pál E; Nagy B; Papp Z
J Reprod Med; 1998 Mar; 43(3):219-22. PubMed ID: 9564650
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive fetal RHD genotyping from maternal plasma. Use of a new developed Free DNA Fetal Kit RhD.
Rouillac-Le Sciellour C; Sérazin V; Brossard Y; Oudin O; Le Van Kim C; Colin Y; Guidicelli Y; Menu M; Cartron JP
Transfus Clin Biol; 2007 Dec; 14(6):572-7. PubMed ID: 18375165
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive fetal RhD genotyping from maternal blood.
Kolialexi A; Tounta G; Mavrou A
Expert Rev Mol Diagn; 2010 Apr; 10(3):285-96. PubMed ID: 20370586
[TBL] [Abstract][Full Text] [Related]
19. Fetal blood group genotyping: present and future.
Daniels G; Finning K; Martin P; Summers J
Ann N Y Acad Sci; 2006 Sep; 1075():88-95. PubMed ID: 17108196
[TBL] [Abstract][Full Text] [Related]
20. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
Lo YM; Hjelm NM; Fidler C; Sargent IL; Murphy MF; Chamberlain PF; Poon PM; Redman CW; Wainscoat JS
N Engl J Med; 1998 Dec; 339(24):1734-8. PubMed ID: 9845707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
